🚨🚨Woodland 1C right now🚨🚨#UKKW2023

Frailty - Adam Gordon MBE - Key paper #UKKW2023 thelancet.com/journals/lance…

Frailty - Adam Gordon MBE - low-cost systematic method for scoring frailty through EPR #UKKW2023 thelancet.com/journals/lance…

Frailty interventions - KOKU project - sounds pretty similar to what we already have through @beam_kidney, well embedded in the kidney community - what am I missing? kokuhealth.com #UKKW2023

Big takeaway for me from #UKKW2023 (from multiple sessions, Jonathan Barratt and others) - substantial risk of progression of IGAN to ESRD even in groups who might be considered low risk - borderline CKD, minimal proteinuria.

That's pretty much a wrap for #UKKW2023. See you all at #UKKW2024, wherever it might be...

So proud of this team.

Professor Bruce Gutherie- only 2% on people with CKD don’t live with another condition #ukkw2024

Wonderful tributes to Donal O'Donoghue to introduce his named lecture at #UKKW2024, from both his wife Marie O’Donoghue and speaker Sharlene Greenwood. A true champion of the MDT at the centre of kidney care. Here’s the time he got hold of my phone at #UKKW2014

Ellis - #realisticmedicine programme - balancing patient priorities, effective interventions and cost across NHS in Scotland realisticmedicine.scot #UKKW2024

#UKKW2024

Two great challenges from Morgan Grams Morgan Grams at #UKKW2024 - 1. Be sure our higher risk patients get access to the drugs they need - 2. Base decisions in lower risk patients on individualised absolute risk reduction - RAASi might be enough! ckdpc.org/risk-models.ht…

Lovely few days in #Edinburgh for #UKKW2024, and looking forward to some informal network building opportunities in Bournemouth #UKKW2025 open.spotify.com/track/50VJqWMA…

🚨🚨Room 6a Right Now 🚨🚨#KidneyWk

Love to know how they came up with the name for the Kidney Action team #kidneywk

Looks like Hiddo Heerspink and team have opened the door to use of GLP1a for renal protection in proteinuric non-diabetic kidney disease… #KidneyWk nature.com/articles/s4159…

EMPAKIDNEY post trial extended follow up from Will Herrington - sustained and meaningful improvements in cardiovascular and renal outcomes #KidneyWk nejm.org/doi/full/10.10…

EMPA-KIDNEY post-trial f-up has revealed helpful findings on #SGLT2i in #CKD. We hope residual uncertainties r resolving & more pts r treated early & long-term. Deep gratitude to 1600+ collaborators & 6609 pts.#KidneyWk Natalie Staplin @RichardHaynes3 Martin Landray Oxford Population Health (OxPop)

See you on the other side 🦋 nephjc.com/news/2024/11/1… #NephJC #NephSky #SkyNeph

Gloucester Renal Gloucestershire Hospitals NHS Foundation Trust We are super excited to announce the first SOUTH-WEST 🇬🇧Glomerulonephritis 🫘 Day. With an amazing group of National/International expert panelist & speakers we look forward to see you there. RCP approved with 6 CPD points.